Viewing Study NCT03091257


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-02-25 @ 5:35 PM
Study NCT ID: NCT03091257
Status: RECRUITING
Last Update Posted: 2025-09-10
First Post: 2017-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module